Launching a blockbuster drug in the U.S. dermatology market

THE CHALLENGE

A siloed team structure creates potential friction for launch execution

Our client was preparing to launch a highly anticipated therapy for psoriasis in the ultra-competitive U.S. Dermatology market. A novel Mechanism of Action (MOA) made the drug a potential blockbuster. The client had to manage the launch with cross-functional collaboration through to FDA approval. However, the siloed structure of the commercial team made this particularly challenging. At a time when leadership was all eyes on the asset, limited visibility into how the critical launch elements were developing did not help.

OUR SOLUTION

Leadership, coordination, and a clearer view

We provided project management leadership and critical cross-functional coordination across six commercial teams to:

• Ensure consistent progress in sync with the launch timeline
• Provide the Launch Leadership Team with a clearer view on progress

The a-connect team focused on delivering against six key objectives:

• Development, management, and tracking of launch milestones, interdependencies, and timelines across 100+ cross-functional stakeholders
• Establishment of launch governance structure and facilitation of cross-functional launch workstreams
• Discovery of launch readiness risks and implementation of mitigation strategies
• Design and facilitation of ‘Patient & HCP Journey Days’ to identify tactical gaps, redundancies, and potential solutions
• Prioritization of the medical, legal, and regulatory review of 300+ pieces of marketing collateral to ensure compliance
• Organization and facilitation of pre-launch offsite meetings for the Launch Leadership Team

THE RESULTS

A seamless launch with exceptional learnings

A highly efficient and timely launch that delivered on the expectations of the executive team, HCPs (Healthcare professionals), and patients. A post-launch retrospective analysis enabled the capture of learnings and knowledge transfer to benefit future launches within the organization.